2. Signaling Pathways
  3. Others
  4. Drug Derivative

Drug Derivative

Drug derivative

Drug derivatives are derived from parent compounds. They replace or add atoms and groups through chemical reactions to optimize the various properties of the parent compound and reduce side effects. The application of drug derivatives provides a diverse compound library for drug research and development and accelerates the discovery of new drugs. For example, urea derivatives Glibenclamide can prolong the blood sugar-lowering effect of anti-diabetic drugs.

Drug Derivative Related Products (1342):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-149683
    WAY-639228
    		≥98.0%
    WAY-639228-A is an active molecule.
    WAY-639228
  • HY-129953C
    5-trans Prostaglandin F2α tromethamine
    5-trans Prostaglandin F2α tromethamine is a derivative of 5-trans Prostaglandin F2α (HY-129953A). 5-trans Prostaglandin F2α is an endogenous metabolite present in blood that can be used for the research of myocardial infarction.
    5-trans Prostaglandin F2α tromethamine
  • HY-127036
    Tocamphyl
    Tocamphyl is an active compound.
    Tocamphyl
  • HY-W015449
    2-(2-Aminopropanamido)propanoic acid
    2-(2-Aminopropanamido)propanoic acid is an alanine derivative.
    2-(2-Aminopropanamido)propanoic acid
  • HY-124242
    (S)-α-Methylbenzyl ricinoleamide
    (S)-α-Methylbenzyl ricinoleamide (compound (R,S)-3d) is a fatty acid amide. (S)-α-Methylbenzyl ricinoleamide shows antiproliferative activity, inhibits the growth of human ovarian cancer cells NCI-ADR/RES and glioma cells U251 with GI50s of 1.9 μg/mL and 3.6 μg/mL, respectively.
    (S)-α-Methylbenzyl ricinoleamide
  • HY-129742
    JTT-010
    JTT-010 is an active compound.
    JTT-010
  • HY-115365
    (3β,20E)-24-Norchola-5,20(22)-diene-3,23-diol
    		≥98.0%
    (3β,20E)-24-Norchola-5,20(22)-diene-3,23-diol is a steroid-based allylic alcohol.
    (3β,20E)-24-Norchola-5,20(22)-diene-3,23-diol
  • HY-129726
    FR-900137
    FR-900137 is an active compound.
    FR-900137
  • HY-158806
    3,4-DHMA TFA
    3,4-DHMA (3,4-Dihydroxymethamphetamine) TFA is an active metabolite of 3,4-MDMA.
    3,4-DHMA TFA
  • HY-133644
    Tribromoacetonitrile
    Tribromoacetonitrile is a nitrogen-containing disinfection byproduct.
    Tribromoacetonitrile
  • HY-164568
    7β,16α-Dihydroxybufalin
    7β,16α-Dihydroxybufalin is a dihydroxylated derivative of bufalin, which exhibits cytotoxicities against cancer cell lines.
    7β,16α-Dihydroxybufalin
  • HY-P3385
    Rilunermin alfa
    Rilunermin alfa (SCB-313) is an active compound. Rilunermin alfa can be used for various biochemical studies.
    Rilunermin alfa
  • HY-121985
    Protheobromine
    Protheobromine is a cardiotonic and bronchodilator
    Protheobromine
  • HY-125548
    Antradion
    Antradion is a Phenylbutazone (HY-B0230) analogue.
    Antradion
  • HY-133933
    Maleylsulfathiazole
    Maleylsulfathiazole is an N4-dibasic acid-substituted sulfonamides.
    Maleylsulfathiazole
  • HY-145441
    GEM–IB
    GEM–IB is the conjugate of gemcitabine (GEM)-5'-phosphate with ibandronate (IB). GEM–IB as a single agent or in combination with Docetaxel (DTX) demonstrates reduced tumor burden, preservation of the bone architecture, and improved the survival in a murine model of osteosarcoma (OS).
    GEM–IB
  • HY-W614957R
    Capecitabine-2',3'-cyclic carbonate (Standard)
    Capecitabine-2',3'-cyclic carbonate (Standard) is the analytical standard of Capecitabine-2',3'-cyclic carbonate. This product is intended for research and analytical applications. Capecitabine-2',3'-cyclic carbonate (Compd 5a) is a 5'-deoxy-5-fluorocytidine derivative with anticancer activity.
    Capecitabine-2',3'-cyclic carbonate (Standard)
  • HY-107835
    Flumethrin
    Flumethrin is an active compound.
    Flumethrin
  • HY-125550
    Doramectin aglycone
    Doramectin aglycone is an active compound.
    Doramectin aglycone
  • HY-160764
    N6-Carboxymethyl-ATP
    N6-Carboxymethyl-ATP is the alkylation product of ATP with iodoacetic acid at pH 6.5, where alkylation of ATP with iodoacetic acid at pH 6.5 yielded 1-carboxymethyl-ATP which, after alkaline rearrangement gave N6-carboxymethyl-ATP.
    N6-Carboxymethyl-ATP